|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in the United States |
|
|
|
|
€ 200,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Septembre 2008 |
Taille du document : |
34 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
OTC Vitamins and Dietary Supplements in Germany 10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in Germany' Major Market Profile report offers an introduction to the market. It is c. 10 pages long and provides a top line ov |
198,00 €
|
| |
| |
UK Analgesics 2004 12 pages | Juillet 2004 |
Snapdata's UK Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK analgesic market, and covers non |
240,00 €
|
| |
| |
US Pregnancy & Ovulation Test Kits 2004 12 pages | Novembre 2004 |
Snapdata's US Pregnancy & Ovulation Test Kits 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US pregnancy a |
240,00 €
|
| |
| |
UK Hayfever Remedies 2004 13 pages | Juillet 2004 |
Snapdata's UK Hayfever Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK hayfever remedy market, a |
240,00 €
|
| |
| |
US Nasal Products 2004 13 pages | Juillet 2004 |
Snapdata's US Nasal Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US nasal product market, and co |
240,00 €
|
| |
| |
US Analgesics 2004 14 pages | Juillet 2004 |
Snapdata's US Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US analgesic market, and covers non |
240,00 €
|
| |
| |
The Pharmaceutical OTC Market to 2010 130 pages | Février 1999 |
Survey : Datamonitor's survey identifies the role that the OTC market plays within the healthcare environment and the current and future dynamics of the industry in terms of OTC therapies and in |
795,00 €
|
| |
| |
Poland Contraceptives 2004 12 pages | Juillet 2004 |
Snapdata's Poland Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the Polish contraceptive market |
240,00 €
|
| |
| |
US First Aid 2004 16 pages | Juillet 2004 |
Snapdata's US First Aid 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US first aid market, and covers trea |
240,00 €
|
| |
| |
UK Cough Cold & Throat Remedies 2004 12 pages | Juillet 2004 |
Snapdata's UK Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK cough, cold an |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in the United States |
|
|
Datamonitor's OTC Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Scope * Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of the industry’s recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards * Includes a five-year forecast of the industry
* The leading companies are profiled with supporting key financial metrics * Supported by the key macroeconomic and demographic data affecting the market Highlights * Detailed information is included on market size, measured by both value and volume * Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
* Market shares are covered by manufacturer and/or brand
* Also features market breakdown by distribution channel Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.
For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
The global figure comprises the Americas, Asia-Pacific and Europe.
|
|
TABLE OF CONTENTS EXECUTIVE SUMMARY 3 CHAPTER 1 Market Overview 3 1.1 Market Definition 3 1.2 Research Highlights 3 1.3 Market Analysis 3 CHAPTER 2 Market Value 3 CHAPTER 3 Market Segmentation I 3 CHAPTER 4 Market Segmentation II 3 CHAPTER 5 Market Share 3 CHAPTER 6 Five Forces Analysis 3 6.1 Summary 3 6.2 Buyer Power 3 6.3 Supplier Power 3 6.4 New Entrants 3 6.5 Substitutes 3 6.6 Rivalry 3 CHAPTER 7 Leading Companies 3 7.1 Wyeth 3 7.2 Pfizer Inc 3 7.3 GlaxoSmithKline Plc 3 CHAPTER 8 Distribution 3 CHAPTER 9 Market Forecasts 3 9.1 Market Value Forecast 3 CHAPTER 10 Macroeconomic Indicators 3 CHAPTER 11 Appendix 3 11.1 Methodology 3 11.2 Industry Associations 3 11.3 Related Datamonitor Research 3 LIST OF TABLES Table 1: United States OTC Pharmaceuticals Market Value: $ billion, 2003-2007 3 Table 2: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 3 Table 3: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 3 Table 4: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007 3 Table 5: Key Facts: Wyeth 3 Table 6: Key Financials: Wyeth 3 Table 7: Key Facts: Pfizer Inc 3 Table 8: Key Financials: Pfizer Inc 3 Table 9: Key Facts: GlaxoSmithKline Plc 3 Table 10: Key Financials: GlaxoSmithKline Plc 3 Table 11: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2007 3 Table 12: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 3 Table 13: United States Size of Population (million) , 2003-2007 3 Table 14: United States GDP (Constant 2000 Prices, $ billion), 2003-2007 3 Table 15: United States Inflation, 2003-2007 3
|
|
|
PPLSEN
|
|
|
|
|